Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test

▴ Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test
FELUDA is actually an acronym - FNACS9 Editor Linked Uniform Detection Assay (FELUDA) – for an indigenous test for rapid diagnosis of Covid-19.

India’s first COVID-19 detecting paper strip ‘Feluda’ delivers results within minutes! One of the most pertinent questions going on in everyone’s head is if they are infected with Coronavirus but have no symptoms? In a matter of minutes, courtesy writer and film-maker Satyajit Ray’s popular fictional detective, ‘Feluda,’ could now clear all your doubts. The ‘Feluda’ is a paper-based test strip that detects the latest coronavirus in an hour, and can now be the solution to the urgent need for rapid testing in India, a LiveMint report indicates.

A team led by two scientists of Bengali descent, Dr. Souvik Maiti and Dr. Debojyoti Chakraborty, at the Institute of Genomics and Integrative Biology (CSIR-IGIB) of the Council of Science & Industrial Research in New Delhi, have come up with a simple strip-test to tell you if you have COVID-19 in minutes, a New18 report has stated. The study uses the state-of-the-art gene-editing tool-Crispr-Cas9 to target and identifies genomic sequences of the novel coronavirus in suspected individual samples.

The kit is similar to a compact paper-strip test used to confirm pregnancy and is much less complex and needs no specific professional expertise to perform. The team led by Dr Souvik Maiti and Dr Debjyoti Chakraborty is currently testing the package in a patient population for its accuracy and responsiveness and hopes to obtain approval within a week from an Indian Medical Research Council (ICMR) regulatory body.

Unlike the real-time PCR test currently being used for Covid-19 diagnosis in India, which costs about 4500, the paper-strip test costs less than 500. It also does not rely on expensive real-time PCR machines for RNA isolation, DNA conversion, and amplification which are already in limited supply, the News18 report indicated.

Although this method has been tested by scientists in other countries including Stanford University and the Massachusetts Institute of Technology (MIT), it is the first such indigenous test kit to be developed in India based on CRISPR technology.

This testing method can be a boon for India where lockdown is about to end and people will have to come back to work. The ability to know if they have Coronavirus infection or not will help firms and employees in decision making over the resumption of coming to the office for work.

Tags : #FeludaCovidTest #FNACS9EditorLinkedUniformDetectionAssay #StanfordUniversity #MIT #MadeInIndiaCovidTest #LatestCovidNewsUpdateSep21 #LatestCovidTestingNewsUpdateSep21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024